Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| 89BIO | 33 | - | +85,46 % | ||
| BIOGEN | 12 | 54 | +0,08 % | ||
| ARVINAS | 10 | 6 | -1,90 % | ||
| RIGEL PHARMACEUTICALS | 7 | - | 0,00 % | ||
| INTELLIA THERAPEUTICS | 6 | 5 | +23,93 % | ||
| BIONTECH | 5 | 13 | -0,90 % | ||
| VERTEX PHARMACEUTICALS | 4 | 5 | -0,11 % | ||
| HUMACYTE | 4 | 4 | +15,36 % | ||
| ROIVANT SCIENCES | 4 | 3 | -2,05 % | ||
| CRISPR THERAPEUTICS | 4 | 1 | +4,42 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19:13 | SONDERMITTEILUNG AM ABEND: Freitag platzt die Bombe bei BioNtech! Das müssen Anleger jetzt wissen! | Felix Haupt | |||
| 19:06 | A Look Into Biogen Inc's Price Over Earnings | 2 | Benzinga.com | ||
| 18:45 | Intnl. Biotechnology - Acquisition of portfolio company 89Bio by Roche | 1 | RNS | ||
| 18:42 | Roche to Acquire 89bio and Phase 3 MASH Candidate in Potential $3.5B Deal | 2 | Contract Pharma | ||
| 18:42 | Roche To Acquire 89bio For $2.4 Billion In Liver And Cardiometabolic Push | 2 | Benzinga.com | ||
| 18:30 | Intellia rises after completion of enrollment in angioedema study | 2 | Seeking Alpha | ||
| 17:46 | Biogen to buy startup Alcyone, eyeing easier delivery of RNA drugs | 2 | BioPharma Dive | ||
| 17:26 | Biogen strikes $85M Alcyone buyout, securing tech for spinal drug delivery | 2 | FierceBiotech | ||
| 17:26 | Carisma's lifeline dissipates as reverse merger plans fall through, Moderna cuts ties | 9 | FierceBiotech | ||
| 17:10 | RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline | 3 | Zacks | ||
| 17:06 | Significant Move: David Santos Invests $90K In Rigel Pharmaceuticals Stock Options | 1 | Benzinga.com | ||
| 17:06 | Dean Schorno Makes Strategic Play: Invests $90K In Rigel Pharmaceuticals Stock Options | 3 | Benzinga.com | ||
| 17:06 | Lisa Rojkjaer Enhances Portfolio With Rigel Pharmaceuticals Stock Options: $90K Acquired | 2 | Benzinga.com | ||
| 17:06 | Raymond Furey At Rigel Pharmaceuticals Secures Company Stock Options: $90K Acquired | 2 | Benzinga.com | ||
| 17:06 | CEO At Rigel Pharmaceuticals Acquires Company Stock Options Worth $388K | 1 | Benzinga.com | ||
| 16:48 | Roche deal to buy 89bio boosts MASH space | 2 | Seeking Alpha | ||
| 16:46 | Intellia-Aktie steigt nach Abschluss der Patientenrekrutierung für Phase-3-Studie zu HAE | 38 | Investing.com Deutsch | ||
| 16:46 | Roche dives into MASH with $2.4B deal for 89bio | 2 | BioPharma Dive | ||
| 16:37 | AstraZeneca erweitert Datenbasis für AIRSUPRA | 236 | FXStreet | AstraZeneca hat die Verschreibungsinformationen für AIRSUPRA in den USA angepasst. Anlass dafür sind neue Ergebnisse der Phase-IIIb-Studie BATURA, die den Einsatz des Präparats bei Erwachsenen mit leichter... ► Artikel lesen | |
| 16:34 | Rigel Gains 77% in 3 Months: Is This an Indication to Buy the Stock? | 1 | Zacks |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .